Glassman Wealth Services Natera, Inc. Transaction History

Glassman Wealth Services

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$37.55 - $62.64 $375 - $626	-10 Reduced 3.8%	253 $15,000
Q3 2023 Nov 13, 2023	SELL	$43.4 - $62.52 $260 - $375	-6 Reduced 2.23%	263 $11,000
Q1 2023 May 04, 2023	BUY	$36.57 - $58.29 $219 - $349	6 Added 2.28%	269 $14,000
Q4 2022 Feb 06, 2023	BUY	$34.17 - $47.91 $4,852 - $6,803	142 Added 117.36%	263 $10,000
Q3 2022 Nov 09, 2022	BUY	$36.93 - $56.68 $3,508 - $5,384	95 Added 365.38%	121 $5,000
Q2 2022 Aug 04, 2022	SELL	$28.13 - $44.54 $8,101 - $12,827	-288 Reduced 91.72%	26 $1,000
Q1 2022 Apr 14, 2022	BUY	$30.32 - $91.33 $8,974 - $27,033	296 Added 1644.44%	314 $13,000
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $8,626 - $11,900	-100 Reduced 84.75%	18 $2,000
Q3 2021 Nov 10, 2021	BUY	$100.17 - $126.36 $10,618 - $13,394	106 Added 883.33%	118 $13,000
Q2 2021 Aug 04, 2021	BUY	$86.05 - $119.72 $258 - $359	3 Added 33.33%	12 $1,000
Q1 2021 May 05, 2021	BUY	$91.47 - $124.36 $91 - $124	1 Added 12.5%	9 $1,000
Q1 2020 May 12, 2020	SELL	$17.27 - $40.17 $189 - $441	-11 Reduced 57.89%	8 $0
Q3 2019 Nov 01, 2019	BUY	$25.38 - $34.89 $228 - $314	9 Added 90.0%	19 $1,000
Q2 2019 Aug 08, 2019	BUY	$17.75 - $27.58 $177 - $275	10 New	10 $0

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.